Journal of managed care & specialty pharmacy

The consequences of pharmaceutical tariffs in the United States.

The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study.

Pediatric-onset rare disease therapy pipeline yields hope for some and gaps for many: 10-year projection of approvals, treated patients, and list price revenues.

Trends in first-line glucose-lowering medication use among US adults with type 2 diabetes from 2019 to 2023.

Changes in blood pressure, medication adherence, and cardiovascular-related health care use associated with the 2018 angiotensin receptor blocker recalls and drug shortages among patients with hypertension.

Health care costs and resource utilization among patients with myasthenia gravis in the United States.

The consequences of pharmaceutical tariffs in the United States.

The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study.

Pediatric-onset rare disease therapy pipeline yields hope for some and gaps for many: 10-year projection of approvals, treated patients, and list price revenues.

Trends in first-line glucose-lowering medication use among US adults with type 2 diabetes from 2019 to 2023.

Changes in blood pressure, medication adherence, and cardiovascular-related health care use associated with the 2018 angiotensin receptor blocker recalls and drug shortages among patients with hypertension.

Health care costs and resource utilization among patients with myasthenia gravis in the United States.